
Pharmacally
Insomnia
Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.
Latest in Insomnia
Health TidingsIdorsia’s Daridorexant Shows Sleep Benefits in Children With InsomniaIdorsia’s Phase 2 study of daridorexant in children and adolescents with insomnia demonstrated a significant dose-response relationship for objectively measured sleep duration.Fact-Checked
Health TidingsMHRA Starts Evaluation of Eisai’s Lemborexant for Adult InsomniaEisai Co., Ltd. announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has accepted its Marketing Authorization Application (MAA) for lemborexant (Dayvigo), a dual orexin receptor…Fact-Checked
Clinical TrialsAvecho Advances Phase III CBD Insomnia Trial After Positive Interim Review Supports Original Enrollment PlanAvecho Biotechnology has achieved a key milestone in its pivotal Phase III trial of the TPM®‑enhanced cannabidiol (CBD) soft‑gel capsule for chronic insomnia.Fact-Checked
Clinical TrialsBeyond Adults: Idorsia’s Daridorexant Shows Promise in Pediatric InsomniaIdorsia’s daridorexant improved total sleep time in children with insomnia in a Phase 2 study, with placebo-like safety and no next-day residual effects, supporting its potential in pediatric…Fact-Checked
Explore more
Health TidingsIndustry, pipeline and company news.
RegulatoryApprovals, policy and agency decisions.
ResearchPeer-reviewed studies and scientific breakthroughs.
Drug FinderLook up any drug: uses, dosing and safety.
From the HistoryLandmark moments in pharmaceutical history.
LatestEvery new story, as soon as it is published.